Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001, 98: 10869-10874. 10.1073/pnas.191367098.
Article
PubMed
PubMed Central
Google Scholar
Rizzo P, Miao H, D’Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L: Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008, 68: 5226-5235. 10.1158/0008-5472.CAN-07-5744.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rose DP, Vona-Davis L: Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas. 2010, 66: 33-38. 10.1016/j.maturitas.2010.01.019.
Article
PubMed
Google Scholar
Newman G, Gonzalez-Perez RR: Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol. 2013, 382 (25): 570-582.
PubMed
Google Scholar
Mohamed A, Krajewski K, Cakar B, Ma CX: Targeted therapy for breast cancer. Am J Pathol. 2013, 183: 1096-1112. 10.1016/j.ajpath.2013.07.005.
Article
CAS
PubMed
Google Scholar
Stylianou S, Clarke BR, Brennan K: Aberrant activation of notch signaling in human breast cancer. Cancer Res. 2006, 66: 1517-1525. 10.1158/0008-5472.CAN-05-3054.
Article
CAS
PubMed
Google Scholar
Guo S, Liu M, Gonzalez-Perez RR: Role of notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 1815, 2011: 197-213.
Google Scholar
Shi W, Harris AL: Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia. 2006, 11: 41-52. 10.1007/s10911-006-9011-7.
Article
CAS
PubMed
Google Scholar
Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G, Egan SE: High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005, 65: 8530-8537. 10.1158/0008-5472.CAN-05-1069.
Article
CAS
PubMed
Google Scholar
Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Sarkar FH: Targeting notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta. 1806, 2010: 258-267.
Google Scholar
Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, Cheung LW, Sonenshein G, Osborne BA, Miele L: Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene. 2010, 29: 201-213. 10.1038/onc.2009.323.
Article
CAS
PubMed
Google Scholar
Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Erşahin Ç, Rajan P: Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol. 2012, 20: 139-145.
Article
PubMed
Google Scholar
Lee CW, Simin K, Liu Q, Plescia J, Guha M, Khan A, Hsieh C-C, Altieri DC: A functional Notch–survivin gene signature in basal breast cancer. Breast Cancer Res. 2008, 10: R97-10.1186/bcr2200.
Article
PubMed
PubMed Central
Google Scholar
WHO: World Health Organization Fact Sheet for World Wide Prevalence of Obesity. 2006, http://www.who.int/mediacentre/factsheets/fs311/en/index.html,
Google Scholar
Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA: Body mass index before and after breast cancer diagnosis: associations with All-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1403-1409. 10.1158/1055-9965.EPI-08-1094.
Article
PubMed
PubMed Central
Google Scholar
Khandekar MJ, Cohen P, Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011, 11: 886-895. 10.1038/nrc3174.
Article
CAS
PubMed
Google Scholar
Guo S, Gonzalez-Perez RR: Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer. PloS One. 2011, 6: e21467-10.1371/journal.pone.0021467.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gillespie C, Quarshie A, Penichet M, Gonzalez-Perez RR: Potential role of leptin signaling in DMBA-induced mammary tumors by Non-responsive C57BL/6 J mice Fed a high-Fat diet. J Carcinogene Mutagene. 2012, 3: 132-
Google Scholar
Battle M, Gillespie C, Quarshie A, Lanier V, Torroella-Kouri M, Gonzalez-Perez RR: Obesity induced leptin-Notch signaling axis in breast cancer. Int J Cancer. 2014, 134: 1606-1616.
Article
Google Scholar
Gonzalez-Perez RR, Lanier V, Newman G: Leptin’s proangiogenic signature in breast cancer. Cancers. 2013, 5: 1140-1162. 10.3390/cancers5031140.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR: Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem. 2006, 281: 26320-26328. 10.1074/jbc.M601991200.
Article
CAS
PubMed
Google Scholar
Saxena NK, Vertino PM, Anania FA, Sharma D: Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem. 2007, 282: 13316-13325. 10.1074/jbc.M609798200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferla R, Bonomi M, Otvos L, Surmacz E: Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects. BMC Cancer. 2011, 11: 303-
Article
CAS
PubMed
PubMed Central
Google Scholar
Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR: Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 1825, 2012: 207-222.
Google Scholar
Gonzalez RR, Leary K, Petrozza JC, Leavis PC: Leptin regulation of interleukin-1 (IL-1) system in endometrial cells. Mol Hum Reprod. 2003, 9: 151-158. 10.1093/molehr/gag022.
Article
CAS
PubMed
Google Scholar
Palomino WA, Fuentes A, Gonzalez RR, Gabler F, Boric MA, Vega M, Devoto L: Differential expression of endometrial integrins and progesterone receptor during the window of implantation in normo-ovulatory women treated with clomiphene citrate. Fertil Steril. 2005, 83: 587-593. 10.1016/j.fertnstert.2004.11.020.
Article
CAS
PubMed
Google Scholar
Espinoza I, Miele L: Notch inhibitors for cancer treatment. Pharmacol Ther. 2013, 139: 95-110. 10.1016/j.pharmthera.2013.02.003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen X, Zha X, Chen W, Zhu T, Qiu J, Røe OD, Li J, Wang Z, Yin Y: Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer. Biomed Pharmacother. 2013, 67: 22-30.
Article
CAS
PubMed
Google Scholar
Catalano S, Mauro L, Marsico S, Giordano C, Rizza P, Rago V, Montanaro D, Maggiolini M, Panno ML, Ando S: Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J Biol Chem. 2004, 279: 19908-19915. 10.1074/jbc.M313191200.
Article
CAS
PubMed
Google Scholar
Knight BB, Oprea-Ilies GM, Nagalingam A, Yang L, Cohen C, Saxena NK, Sharma D: Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin induced migration of breast carcinoma cells. Endocr Relat Cancer. 2011, 18: 413-428. 10.1530/ERC-11-0075.
Article
CAS
PubMed
PubMed Central
Google Scholar
Soma D, Kitayama J, Yamashita H, Miyato H, Ishikawa M, Nagawa H: Leptin augments proliferation of breast cancer cells via transactivation of HER2. Surg Res. 2008, 149: 9-14. 10.1016/j.jss.2007.10.012.
Article
CAS
Google Scholar
Giordano C, Vizza D, Panza S, Barone I, Bonofiglio D, Lanzino M, Sisci D, De Amicis F, Fuqua SA, Catalano S, Andò S: Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells. Mol Oncol. 2013, 7: 379-391. 10.1016/j.molonc.2012.11.002.
Article
CAS
PubMed
Google Scholar
Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O’Regan RM, Sharma D: Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res. 2008, 68: 9712-9722. 10.1158/0008-5472.CAN-08-1952.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rene Gonzalez R, Watters A, Xu Y, Singh UP, Mann DR, Rueda BR, Penichet ML: Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res. 2009, 11: R36-10.1186/bcr2321.
Article
PubMed
PubMed Central
Google Scholar
Otvos L, Kovalszky I, Riolfi M, Ferla R, Olah J, Sztodola A, Nama K, Molino A, Piubello Q, Wade JD, Surmacz E: Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer. 2011, 10: 1578-1584.
Article
Google Scholar
Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Erşahin Ç, Rajan P: Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol. 2012, 20: 139-145.
Article
PubMed
Google Scholar
Kim SB, Chae GW, Lee J, Park J, Tak H, Chung JH, Park TG, Ahn JK, Joe CO: Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation. Cell Death Differ. 2007, 14: 982-991.
PubMed
Google Scholar
Dong Y, Li A, Wang J, Weber JD, Michel LS: Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer. Cancer Res. 2010, 70: 5465-5474. 10.1158/0008-5472.CAN-10-0173.
Article
CAS
PubMed
Google Scholar
Zheng Q, Banaszak L, Fracci S, Basali D, Dunlap SM, Hursting SD, Rich JN, Hjelmeland AB, Vasanji A, Berger NA, Lathia JD, Reizes O: Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr Relat Cancer. 2013, 20: 797-808. 10.1530/ERC-13-0329.
Article
CAS
PubMed
PubMed Central
Google Scholar
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 348: 1625-1638. 10.1056/NEJMoa021423.
Article
PubMed
Google Scholar
Feldman DE, Chen C, Punj V, Tsukamoto H, Machida K: Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proc Natl Acad Sci U S A. 2012, 109: 829-834. 10.1073/pnas.1114438109.
Article
CAS
PubMed
Google Scholar
Gilbert CA, Slingerland JM: Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression. Ann Rev Med. 2013, 64: 45-57. 10.1146/annurev-med-121211-091527.
Article
CAS
PubMed
Google Scholar
Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Bustos M, Martinez JA, Moreno-Aliaga MJ: Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta. 1807, 2011: 664-678.
Google Scholar
Zhang Y, Bellows CF, Kolonin MG: Adipose tissue-derived progenitor cells and cancer. World J Stem Cells. 2010, 2: 103-113. 10.4252/wjsc.v2.i5.103.
Article
PubMed
PubMed Central
Google Scholar
Wang Y, Mi J, Shan XY, Wang QJ, Ge KY: Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond). 2007, 1: 177-188.
Article
Google Scholar